Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alexandra Žourková"'
Autor:
Alexandra Žourková
Publikováno v:
Psychiatrie pro praxi. 23:192-194
Publikováno v:
Psychiatrie pro praxi. 20:29-31
Sexualni dysfunkce při lecbě serotonergnimi antidepresivy jsou casto popisovany a mohou vest až k nonadherenci. Nove antidepresivumvortioxetin se jevi jako ucinne bez negativnich vlivů na sexualni funkce. Vortioxetin měl kladný vliv na sexualni
Autor:
Jana Novotná, Alexandra Žourková
Publikováno v:
International journal of psychiatry in clinical practice. 10(3)
Objects. To evaluate the effect of trazodone on depressive or anxiety symptoms and sexual function depending on patient gender. Method. A total of 111 patients (59 men, 52 women) subjected to long-term treatment with trazodone were studied. The effec
Autor:
Eva Pindurová, Michaela Cvanová, Alexandra Žourková, Ondřej Slanař, Jiří Jarkovský, Ivana Palčíková
Publikováno v:
Journal of sexmarital therapy. 39(1)
Paroxetine-induced sexual dysfunction represents a frequent treatment complication of otherwise efficient antidepressants. The genetic polymorphism of pharmacokinetic genes may contribute to the occurrence of such dysfunctions. This study presents th
Publikováno v:
Molecular biotechnology. 53(1)
High-resolution melting curve analysis (HRM) of polymerase chain reaction (PCR) amplicons has been described as a fast, cheap, and reliable closed-tube method of genotyping with no need for labeled primers or labeled probes. We adapted this melting a
Autor:
Richard, Barteček, Jan, Juřica, Jana, Zrůstová, Tomáš, Kašpárek, Eva, Pindurová, Alexandra, Žourková
Publikováno v:
Neuro endocrinology letters. 33(2)
The objective of this prospective, naturalistic study, conducted in first-episode psychosis patients from a Central-European population, was to assess the utility of Cytochrome P-450 2D6 (CYP2D6) genotype testing under normal clinical setting.A total
Publikováno v:
European Neuropsychopharmacology. 13:S291
In double-blind randomized trial olanzapine was more suitable antipsychotic for the treatment of first-episode psychoses for the greater final improvement, better reduction of negative symptoms a fewer extrapyramidal side -effects and hyperprolactine
Publikováno v:
ResearcherID
IntroductionRisperidone is an antipsychotic used as the first-line treatment of schizophrenia. Risperidone is metabolised by enzyme CYP2D6. Activity of this enzyme can be predicted by genotypization.ObjectivesTo explore the possibility of different r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51222df7ea1987ad39bb35a953f017c2
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000208641301148&KeyUID=WOS:000208641301148
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000208641301148&KeyUID=WOS:000208641301148